Shattuck Labs downgraded by H.C. Wainwright
$STTK
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright downgraded Shattuck Labs from Buy to Neutral
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/17/2025 | $4.00 | Outperform | Leerink Partners |
10/2/2024 | $8.00 → $2.00 | Buy → Neutral | Citigroup |
10/2/2024 | Buy → Hold | Needham | |
10/1/2024 | Buy → Neutral | H.C. Wainwright | |
6/17/2024 | Buy → Neutral | BTIG Research | |
8/31/2022 | $12.00 | Buy | BTIG Research |
6/1/2022 | $13.00 | Buy | Citigroup |
5/2/2022 | $28.00 | Buy | H.C. Wainwright |
4 - Shattuck Labs, Inc. (0001680367) (Issuer)
4 - Shattuck Labs, Inc. (0001680367) (Issuer)
4 - Shattuck Labs, Inc. (0001680367) (Issuer)